Press Releases

2025 was a year of tenacity, strategic transactions and building traction for RedHillTalicia® business transformed:Formation of Talicia Holdings Inc. (THI) and the U.S. co-commercialization partnership with Cumberland Pharmaceuticals ("Cumberland") (NASDAQ:CPIX), including Cumberland's $4 million investment for a 30% equity interest in THI planned to drive Talicia growth, and potentially additional revenue generating products. Cumberland and Apotex1, Canadian-based global health company, have since announced their planned strategic transaction to integrate Cumberland's U.S branded business into ApotexAdded eight million lives with coverage by Humana®'s Part D Plan and published new data supp

Guidelines include the next-generation targeted therapy as a systemic option for patients with ROS1-positive non-small cell lung cancer with brain metastasesNEW YORK, April 27, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that taletrectinib (IBTROZI®) has been added to the latest National Comprehensive Cancer Network® Clinical Practice Guidelines (NCCN Guidelines®) in Oncology for Central Nervous System (CNS) cancers, updated on April 24, 2026. Specifically, the NCCN Guidelines® for CNS Cancers now recommend taletrectinib (IBTROZI) as a systemic therapy option for ROS1-po

LOS ANGELES, April 27, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced Vice President of Technology, Yue ("Robin") Ma, will deliver a featured presentation at the World Dialogue on Art and Technology Conference to be held April 25-29, 2026 at Shanghai University in Beijing.Ma is one of eight distinguished keynote speakers invited to present at the conference. Her speech entitled "From Cinematic High Frame Rate to Immersive Cinema " will discuss how Pixelworks' TrueCut Motion technology bridges cinematic tradition and experiential features by modeling human visual perc

New VIN-Specific, AI-Powered Video Ads — Fueled by Real-Time Shopper Demand and Closed-Loop Attribution — Deliver 47% Lift in Influenced SalesCHICAGO, April 27, 2026 /PRNewswire/ -- Car-shopping marketplace Cars.com Inc. (NYSE:CARS) today shared new data around its powerful artificial intelligence (AI) video advertising solution that automatically converts dealer inventory into shopper-ready video assets. A pilot program was announced earlier this year at NADA Show 2026, and the company officially rolled out its first live campaign in March. Cars.com is the only company in the industry to provide a solution that combines VIN-specific, AI-powered video ads with real, in-market consumer demand

TORONTO, April 27, 2026 /CNW/ - Paramount in Canada and Media Pulse, a Blue Ant Media company, today announced an expanded partnership, naming Media Pulse as the exclusive direct sales and programmatic partner for Paramount's ad inventory in Canada. Media Pulse will represent both Paramount's SVOD platform, Paramount+, and its leading free-streaming service, Pluto TV. This deal enables Media Pulse to offer clients direct ad insertion opportunities across the full breadth of Paramount+ and PlutoTV's premium CTV inventory, enabling Canadian advertisers to reach highly-engaged audiences who enjoy streaming world-class content."This exclusive partnership with Pluto TV and Paramount+ in Canada is

CHICAGO, April 27, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE:TDS) announced the appointment of Bill Case as senior vice president and chief information officer, effective immediately. Case brings deep experience leading complex technology and business transformation in the broadband and digital infrastructure space. Most recently, he served as executive vice president and chief information officer at WOW! Internet, Cable, and Phone, where he was responsible for enterprise technology including IT, cybersecurity, business intelligence, and business transformation initiatives. In that role, Case helped drive improvements across customer experience, product development, and ove

SHANGHAI, April 27, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE:LU), a leading financial services enabler for small business owners in China, today announced that it has appointed Ms. Xiaodi Wang as the Chief Compliance Officer of the Company, with immediate effect. The biographical details of Ms. Wang are set out below.Ms. Xiaodi Wang, aged 42, possesses extensive legal and compliance experience at large financial institutions and has deep expertise in regulatory policies, laws and regulations in the finance industry and corporate governance practices. Ms. Wang joined Ping An Asset Management Co., Ltd. in September 2012 and currently serves as the general manager of the internal control an

SHANGHAI, April 27, 2026 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE:LU), a leading financial services enabler for small business owners in China, today announced  that it will hold an annual general meeting of the Company's shareholders (the "AGM")  on June 30, 2026, for the purposes of considering and, if thought fit, passing each of the proposed resolutions set forth in the AGM notice. The AGM notice, the AGM circular, and the form of proxy for the AGM will be available on the Company's website at https://ir.lufaxholding.com. Holders of record of the Company's ordinary shares on the Company's register of members as of the close of business on May 18, 2026 (Hong Kong

SANTA CLARA, Calif., April 27, 2026 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE:TUYA, HKEX: 2391)), a global leading AI cloud platform service provider, today announced that it will report its first quarter 2026 unaudited financial results after the market closes on Monday, May 11, 2026. Tuya's management will hold a conference call at 08:30 P.M. Eastern Time on Monday, May 11, 2026 (08:30 A.M. Hong Kong Time on Tuesday, May 12, 2026) to discuss the financial results. In advance of the conference call, all participants must use the following links to complete the online registration process. Upon registering, each participant will receive the dial-in information and a unique PI

CLEVELAND, April 27, 2026 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG) today said it will report fiscal 2026 second quarter earnings before the market opens on Tuesday, May 5, 2026. A conference call will follow at 11:00 a.m., Eastern Time. To join the call telephonically, please register for the call here. Once registered, participants will receive the dial-in information and a unique pin to access the call. A live audio webcast of the call can also be accessed online at http://www.transdigm.com.The webcast will be archived on the website and available for replay lat

PETAH-TIKVA, Israel, April 27, 2026 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (NASDAQ:GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the first quarter ended March 31, 2026, before market open on Wednesday, May 13, 2026. Global-e management will host a conference call to review its financial results and outlook.  Date:Wednesday, May 13, 2026 Time:8:00 AM ET United States/Canada Toll Free:+1-800-717-1738 International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Global-e's we

SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ:BLTE), ("Belite Bio" or the "Company"), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will give an oral presentation at the Retinal Therapeutics Innovation Summit being held on May 1, 2026, in Denver, Colorado. The presentation will cover the previously disclosed positive topline results from the Phase 3 DRAGON trial, which evaluated tinlarebant for the treatment of Stargardt disease type 1 (STGD1). In the study, tinlarebant demonstrated a clinically m

BURLINGTON, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ:CRNC) ("Cerence AI"), a global leader pioneering conversational AI-powered user experiences, will announce its second quarter financial results for the quarter ended March 31, 2026, on Thursday, May 7, 2026, at 4:05pm Eastern Time / 1:05pm Pacific Time. The company will host a live conference call and webcast, with supplementary slides, to discuss the results on the same day at 4:30pm Eastern Time / 1:30pm Pacific Time. Interested investors and analysts are invited to join the audio conference call by registering here. Webcast access will be available at investors.cerence.com. To learn more about Cerence AI, visi

RESEARCH TRIANGLE PARK, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Opus Genetics (NASDAQ:IRD) ("Opus Genetics" or the "Company"), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced that members of its leadership team will participate in several leading ophthalmology and industry conferences. "We look forward to sharing progress across our programs at ARVO and other leading meetings this May, including encouraging findings from our LCA5 and BEST1 gene therapy programs," said Dr. George Magrath, Chief Executive Officer, Opus Genetics. "At ARVO, we will present previous

WOBURN, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 29-June 2, 2026. The Company has two abstracts selected for oral presentation, including a 3-year landmark overall survival analysis from the IGNYTE clinical trial of RP1 (vusolimogene oderparepvec) plus nivolumab in anti-PD-1 failed melanoma, and an oral presentation on the final safety, efficacy, and biomarker results from the Phase 1 first-in-human study of RP2

New Q1 2026 "Agentic Commerce Pulse" survey from Riskified reveals a growing trust gap in agent-driven commerce, as consumers embrace AI across the shopping journey but remain hesitant to hand over control amid concerns over fraud, security, and accountability Riskified (NYSE:RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified's inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong,

The companies will jointly deliver a unified customer identity, loyalty, and engagement platform spanning the full home lifecycle Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond") and Bilt today announced a strategic partnership to create a more connected, rewarding, and seamless experience for customers across the Bed Bath & Beyond portfolio, including Bed Bath & Beyond, The Container Store, Kirkland's, Overstock, and buybuy BABY. Together, the companies will bring Bilt's customer identity, loyalty, and engagement platform into Bed Bath & Beyond's growing "Everything Home" ecosystem, thereby creating a shared foundation that recognizes customers across all brands, rewards long-

The Ingles 2026 Annual Meeting Is Being Held This Week on Thursday, April 30th. Shareholders are Urged to Vote TODAY to Ensure Their Vote is Timely Submitted Ingles Markets, Incorporated (NASDAQ:IMKTA) ("Ingles" or the "Company") today reminded shareholders to vote ahead of the 2026 Annual Meeting of Shareholders, which will be held on April 30, 2026 at 10:00 a.m. Eastern Time. The Ingles Board of Directors recommends that all Ingles shareholders vote "FOR" ONLY Ingles' two highly qualified, independent director nominees – Rebekah Lowe and Dwight Jacobs – on the WHITE proxy card. The Ingles Board of Directors issued the following statement: Ingles has a long record of delivering sha

Collaboration focused on discounted prescription and direct delivery services CenterWell Pharmacy®, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions. As part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy® as a pharmacy partner. In addition, Cost Plus Drugs' digital pharmacy SaaS solution, SwiftyRx™, will be used by CenterWell Pharmacy for its medication order intake operations. More broadly, by combining SwiftyRx's innovative technology, Cost Plus Drugs' industry

Cerus Corporation (NASDAQ:CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System. The agreement covers the INTERCEPT Blood System for platelets and plasma as well as the next generation, LED-based INT200 illumination device. "We are proud to announce a new four-year supply agreement with the French Blood Establishment," said Christian Boutemy, Cerus' vice president of international commercial operations. "EFS has been a global leader in the adoption of pathogen inactivation technologies to help safeguard the blood supply and enhance patient safety. This agreement furth